|
|
Time |
Source |
|
Announcement
|
|
| 04 May 2022 |
5:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2022 |
| |
3:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Annual General Meeting of Infant Bacterial Therapeutics |
| 05 Apr 2022 |
7:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics |
| 31 Mar 2022 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics publishes Annual Report for 2021 |
| 04 Feb 2022 |
7:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2021 |
| 19 Jan 2022 |
10:30 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
The Connection Study continues after pre-scheduled Data Monitoring Committee (DMC) review |
| 10 Jan 2022 |
9:30 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics today announces that new patent protection is granted in Australia |
| 27 Dec 2021 |
9:30 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics today announces new patent protection approvals in Brazil and in Hong Kong |
| 10 Dec 2021 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics CFO leaves the company |
| 06 Dec 2021 |
6:47 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
A Blinded Evaluation of the Connection Study – Sustained Feeding Tolerance (SFT) Correlates to Clinical Outcomes |
| 29 Oct 2021 |
3:15 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Nomination Committee appointed for the 2022 Annual General Meeting (AGM) in Infant Bacterial Therapeutics (IBT). |
| |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2021 |
| 30 Sep 2021 |
6:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Next recruitment milestone reached in IBT’s Phase III Study. |
| 22 Sep 2021 |
9:30 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
After safety review The Connection study is now again open to recruit the smallest infants. |
| 10 Sep 2021 |
11:30 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics today announces that a new patent is granted in Mexico |
| 25 Aug 2021 |
11:50 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Recruitment of the smallest infants in the Connection study paused |
| 13 Aug 2021 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2021 |
| 13 Jul 2021 |
4:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB appoints Marie-Louise Alamaa as new CFO |
| 20 May 2021 |
3:30 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics CFO leaves the company |
| 06 May 2021 |
5:50 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Annual General Meeting of Infant Bacterial Therapeutics CEO speech |
| 04 May 2021 |
4:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Annual General Meeting of Infant Bacterial Therapeutics |
| |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2021 |
| 29 Apr 2021 |
9:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics expands The Connection Study to include infants with a birth weight below 750 grams |
| 15 Apr 2021 |
6:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics receives additional patent protection in China |
| 09 Apr 2021 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics publishes Annual Report for 2020 |
| 01 Apr 2021 |
2:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics |
| 10 Feb 2021 |
2:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics announces that the recruitment to the first stage of the Phase III Connection Study is completed - an update about the clinical development of IBP-9414 |
| 09 Feb 2021 |
7:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics today announces that new patent protection is granted in Japan |
| 05 Feb 2021 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2020 |
| 05 Nov 2020 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2020 |
| 14 Aug 2020 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2020 |
| 16 Jun 2020 |
4:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Annual General Meeting of Infant Bacterial Therapeutics |
| 18 May 2020 |
8:30 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics |
| 11 May 2020 |
3:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1-March 31, 2020 |
| 03 Apr 2020 |
1:05 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics publishes Annual Report for 2019 |
| |
1:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB postpones Annual General Meeting |
| 11 Feb 2020 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2019 |
| 07 Nov 2019 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2019 |
| 05 Nov 2019 |
4:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Lilian Wikström Ph.D. has requested to resign from the Board of Directors of Infant Bacterial Therapeutics AB |
| 21 Aug 2019 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2019 |
| 04 Jul 2019 |
1:15 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics has recruited the first patient in the pivotal Phase III clinical study |
| 19 May 2019 |
7:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
FDA and Infant Bacterial Therapeutics agree on the design of Phase III study |
| 06 May 2019 |
5:30 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Annual General Meeting of Infant Bacterial Therapeutics |
| |
12:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2019 |
| 05 Apr 2019 |
4:30 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) |
| 04 Apr 2019 |
7:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
IBT publishes annual report for 2018 |
| 05 Mar 2019 |
4:10 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB announces first distribution agreement |
| 08 Feb 2019 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2018 |
| 21 Nov 2018 |
8:45 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
The Phase III study protocol is modified after IBT’s meeting with the FDA |
| 14 Nov 2018 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2018 |
| 08 Oct 2018 |
10:30 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) announces that the Nomination Committee is appointed for the Annual General Meeting 2019 |
| 04 Sep 2018 |
3:20 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics publishes prospectus in connection with the list change to Nasdaq Stockholm |
| 30 Aug 2018 |
9:30 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics has been approved for listing on the main market of Nasdaq Stockholm |
| 16 Aug 2018 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2018 |
| 26 Jun 2018 |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
IBT plans to start its phase 3 study in the second half of 2018 and contracts CRO |
| 15 May 2018 |
5:00 pm |
GNW
|
|
|
Infant Bacterial Therapeutics |
Annual General Meeting of Infant Bacterial Therapeutics AB |
| |
8:47 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Update: Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 30, 2018 |
| |
7:00 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 30, 2018 |
| 09 May 2018 |
10:30 am |
GNW
|
|
|
Infant Bacterial Therapeutics |
Infant Bacterial Therapeutics AB Nomination Committee modifies its proposal to the Board of Directors |